{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T04:36:32Z","timestamp":1761885392415,"version":"build-2065373602"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/j.acuroe.2022.01.004","type":"journal-article","created":{"date-parts":[[2022,6,29]],"date-time":"2022-06-29T23:47:49Z","timestamp":1656546469000},"page":"613-618","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Surveillance and office management of low-grade Ta bladder tumors"],"prefix":"10.1016","volume":"46","author":[{"given":"S.D.","family":"Lokeshwar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.N.","family":"Rahman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.H.","family":"Press","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.I.","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.S.","family":"Soloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2019","series-title":"Surveillance, Epidemiology, and End Results Program. Cancer Stat Facts: Bladder cancer","author":"National Cancer Institute","key":"10.1016\/j.acuroe.2022.01.004_bib0005"},{"key":"10.1016\/j.acuroe.2022.01.004_bib0010","doi-asserted-by":"crossref","first-page":"1518","DOI":"10.1038\/s41416-018-0084-z","article-title":"Health-related quality of life after treatment for bladder cancer in England","volume":"118","author":"Mason","year":"2018","journal-title":"Br J Cancer."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0015","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/his.13734","article-title":"Staging of bladder cancer","volume":"74","author":"Magers","year":"2019","journal-title":"Histopathology."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0020","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.urology.2005.07.063","article-title":"Low-grade Ta (noninvasive) urothelial carcinoma of the bladder","volume":"66","author":"Oosterlinck","year":"2005","journal-title":"Urology."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0025","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1097\/01.ju.0000149163.08521.69","article-title":"A surveillance schedule for G1Ta bladder cancer allowing efficient use of check cystoscopy and safe discharge at 5 years based on a 25-year prospective database","volume":"173","author":"Mariappan","year":"2005","journal-title":"J Urol."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0030","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1016\/j.juro.2016.06.049","article-title":"Diagnosis and treatment of non-muscle invasive bladder cancer: AUA\/SUO guideline","volume":"196","author":"Chang","year":"2016","journal-title":"J Urol."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0035","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.eururo.2016.05.041","article-title":"EAU guidelines on non\u2013muscle-invasive urothelial carcinoma of the bladder: update 2016","volume":"71","author":"Babjuk","year":"2017","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0040","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.urology.2017.03.034","article-title":"European Association of Urology and American Urological Association\/Society of Urologic Oncology Guidelines on Risk Categories for Non-muscle-invasive Bladder Cancer May Lead to Overtreatment for Low-grade Ta Bladder Tumors","volume":"105","author":"Klaassen","year":"2017","journal-title":"Urology."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0045","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.eururo.2005.12.031","article-title":"Predicting recurrence and progression in individual patients with stage Ta T1 bladder cancer using EORTC risk tables: a combined analysis of 2596 patients from seven EORTC trials","volume":"49","author":"Sylvester","year":"2006","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0050","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1097\/01.ju.0000181797.19395.03","article-title":"Transurethral bladder tumor resection: intraoperative and postoperative complications in a residency setting","volume":"174","author":"Nieder","year":"2005","journal-title":"J Urol."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0055","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1097\/01.ju.0000076621.71247.6c","article-title":"Expectant management of small, recurrent, noninvasive papillary bladder tumors","volume":"170","author":"Soloway","year":"2003","journal-title":"J Urol."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0060","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.eururo.2005.12.030","article-title":"Watchful waiting for low-grade Ta bladder tumours: the idea would have been unacceptable 30 years ago, but nowadays we are highly interested in the results of this study exploring it","volume":"49","author":"Oosterlinck","year":"2006","journal-title":"Eur Urol."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0065","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.juro.2017.08.091","article-title":"Active surveillance for low risk nonmuscle invasive bladder cancer: a confirmatory and resource consumption study from the BIAS project","volume":"199","author":"Hurle","year":"2018","journal-title":"J Urol."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0070","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1016\/S0022-5347(05)64555-7","article-title":"Correlation of cystoscopy with histology of recurrent papillary tumors of the bladder","volume":"168","author":"Herr","year":"2002","journal-title":"J Urol."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0075","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1046\/j.1464-4096.2001.02396.x","article-title":"Does cystoscopy correlate with the histology of recurrent papillary tumours of the bladder?","volume":"88","author":"Herr","year":"2001","journal-title":"BJU Int."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0080","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/S0022-5347(17)49477-8","article-title":"Superficial bladder cancer: comments on evaluation and management","volume":"132","author":"Soloway","year":"1984","journal-title":"J Urol."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0085","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1007\/s00345-015-1548-x","article-title":"Impact of 2004 ISUP\/WHO classification on bladder cancer grading","volume":"33","author":"Lokeshwar","year":"2015","journal-title":"World J Urol."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0090","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/j.juro.2011.07.070","article-title":"Clinical reliability of the 2004 WHO histological classification system compared with the 1973 WHO system for Ta primary bladder tumors","volume":"186","author":"Pellucchi","year":"2011","journal-title":"J Urol."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0095","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/S0022-5347(05)67972-4","article-title":"Tumor progression and survival of patients with high grade, noninvasive papillary (TaG3) bladder tumors: 15-year outcome","volume":"163","author":"Herr","year":"2000","journal-title":"J Urol."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0100","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1016\/S0022-5347(05)66443-9","article-title":"Stage progression in Ta papillary urothelial tumors: relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy","volume":"165","author":"Holm\u00e4ng","year":"2001","journal-title":"J Urol."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0105","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0090-4295(81)90355-1","article-title":"Bladder papilloma: therapeutic and cost effect of outpatient department management","volume":"18","author":"Klein","year":"1981","journal-title":"Urology."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0110","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1016\/S0022-5347(17)39742-2","article-title":"Outpatient flexible cystoscopy and fulguration of recurrent superficial bladder tumors","volume":"144","author":"Herr","year":"1990","journal-title":"J Urol."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0115","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/21681805.2017.1353542","article-title":"Outpatient photodynamic-guided diagnosis of carcinoma in situ with flexible cystoscopy: an alternative to conventional inpatient photodynamic-guided bladder biopsies in the operating theatre?","volume":"51","author":"Mogensen","year":"2017","journal-title":"Scand J Urol."},{"issue":"Suppl 1","key":"10.1016\/j.acuroe.2022.01.004_bib0120","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/anae.12493","article-title":"Should general anaesthesia be avoided in the elderly?","volume":"69","author":"Str\u00f8m","year":"2014","journal-title":"Anaesthesia."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0125","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1097\/01.ju.0000181811.61199.35","article-title":"The actual incidence of bladder perforation following transurethral bladder surgery","volume":"174","author":"Balbay","year":"2005","journal-title":"J Urol."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0130","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1016\/S0022-5347(05)66254-4","article-title":"Outpatient flexible cystoscopy in men: a randomized study of patient tolerance","volume":"165","author":"Herr","year":"2001","journal-title":"J Urol."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0135","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S0022-5347(01)61778-6","article-title":"A prospective trial of flexible cystodiathermy for recurrent transitional cell carcinoma of the bladder","volume":"161","author":"Wedderburn","year":"1999","journal-title":"J Urol."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0140","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.ucl.2013.01.007","article-title":"Office-based bladder tumor fulguration and surveillance: indications and techniques","volume":"40","author":"O\u2019Neil","year":"2013","journal-title":"Urol Clin North Am."},{"key":"10.1016\/j.acuroe.2022.01.004_bib0145","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1002\/cncr.24104","article-title":"Routine perioperative chemotherapy instillation with initial bladder tumor resection: a reconsideration of economic benefits","volume":"115","author":"Rao","year":"2009","journal-title":"Cancer."}],"container-title":["Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578622000622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2173578622000622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T03:15:31Z","timestamp":1761880531000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2173578622000622"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,12]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2173578622000622"],"URL":"https:\/\/doi.org\/10.1016\/j.acuroe.2022.01.004","relation":{},"ISSN":["2173-5786"],"issn-type":[{"type":"print","value":"2173-5786"}],"subject":[],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Surveillance and office management of low-grade Ta bladder tumors","name":"articletitle","label":"Article Title"},{"value":"Actas Urol\u00f3gicas Espa\u00f1olas (English Edition)","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.acuroe.2022.01.004","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.acuro.2022.01.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 AEU. Published by Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}